119 related articles for article (PubMed ID: 11266765)
21. The role of CD30 in skin and heart allograft rejection in the mouse.
Beckmann J; Kurts C; Klebba I; Bayer B; Klempnauer J; Hoffmann MW
Transplant Proc; 2001; 33(1-2):140-1. PubMed ID: 11266747
[No Abstract] [Full Text] [Related]
22. Allograft tolerance induced by cyclophosphamide without prior inoculation of donor cells--immune suppression and redirection.
Gao ZH; Lazarovits AI; Wang J; Xing J; Garcia B; Kellersmann R; Kelvin D; Zhong R
Transpl Immunol; 2000 Mar; 8(1):65-73. PubMed ID: 10834612
[TBL] [Abstract][Full Text] [Related]
23. Induction of peripheral tolerance by posttransplant infusion of donor splenocytes.
Tsui TY; Jäger MD; Deiwick A; Klempnauer J; Schlitt HJ
Transplant Proc; 2001; 33(1-2):187-8. PubMed ID: 11266773
[No Abstract] [Full Text] [Related]
24. Promotion of skin graft tolerance across MHC barriers by mobilization of dendritic cells in donor hemopoietic cell infusions.
Eto M; Hackstein H; Kaneko K; Nomoto K; Thomson AW
J Immunol; 2002 Sep; 169(5):2390-6. PubMed ID: 12193706
[TBL] [Abstract][Full Text] [Related]
25. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Jan; 144(2):463-73. PubMed ID: 2136891
[TBL] [Abstract][Full Text] [Related]
26. The induction of skin xenograft tolerance in rat-to-mouse combination could be affected by DFR mediating cells and antibodies against rat bone marrow cells as well as NK cells in the cyclophosphamide-induced tolerance system.
Nishimura Y; Eto M; Maeda T; Hiromatsu K; Nomoto K; Kong YY; Nomoto K
Immunobiology; 1995 Aug; 193(5):420-38. PubMed ID: 8522358
[TBL] [Abstract][Full Text] [Related]
27. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
[TBL] [Abstract][Full Text] [Related]
28. Indefinite survival of fully allogeneic cardiac grafts induced by antigen delivery through the alimentary tract.
Niimi M; Ikeda Y; Kan S; Shirasugi N; Hamano K
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):629-30. PubMed ID: 11547327
[No Abstract] [Full Text] [Related]
29. Tolerance to vascularized musculoskeletal allografts.
Mathes DW; Bourget JL; Randolph MA; Solari MG; Wu A; Sachs DH; Lee WP
Transplant Proc; 2001; 33(1-2):616-7. PubMed ID: 11266984
[No Abstract] [Full Text] [Related]
30. Amnion-derived multipotent progenitor cells support allograft tolerance induction.
Anam K; Lazdun Y; Davis PM; Banas RA; Elster EA; Davis TA
Am J Transplant; 2013 Jun; 13(6):1416-28. PubMed ID: 23651511
[TBL] [Abstract][Full Text] [Related]
31. Pretreatment with FTY720 alone induced long-term survival of mouse heart allograft.
Zhang L; Zhu T; Sun EW; Shen SQ; Min ZL; Chen ZK
Transplant Proc; 2003 Feb; 35(1):567-8. PubMed ID: 12591534
[No Abstract] [Full Text] [Related]
32. Effects of intrathymic tolerance on mouse heart and skin allograft acceptance.
Tu Y; Arima T; Flye MW
Transplant Proc; 1997; 29(1-2):1063-4. PubMed ID: 9123200
[No Abstract] [Full Text] [Related]
33. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
[No Abstract] [Full Text] [Related]
34. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K
Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220
[No Abstract] [Full Text] [Related]
35. The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
Eur J Immunol; 1990 Sep; 20(9):2005-13. PubMed ID: 2209702
[TBL] [Abstract][Full Text] [Related]
36. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
[TBL] [Abstract][Full Text] [Related]
37. Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells.
Yu G; Fang M; Gong M; Liu L; Zhong J; Feng W; Xiong P; Wang CY; Gong F
Transpl Immunol; 2008 Jan; 18(3):208-19. PubMed ID: 18047928
[TBL] [Abstract][Full Text] [Related]
38. FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK 506 in rat allograft models.
Hoshino Y; Yanagawa Y; Ohtsuki M; Nakayama S; Hashimoto T; Chiba K
Transplant Proc; 1999; 31(1-2):1224-6. PubMed ID: 10083547
[No Abstract] [Full Text] [Related]
39. Anti-CD4 monoclonal antibody reduces the dose of cyclophosphamide required to induce tolerance to H-2 haplotype identical skin allografts in mice.
Omoto K; Nishimura Y; Nomoto K; Kong YY; Umesue M; Murakami Y; Tomita Y; Nomoto K
Immunobiology; 1996 Jan; 195(1):16-32. PubMed ID: 8852598
[TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy of immunosuppressive drugs in xenografting.
Thomas FT; DeMasi RJ; Araneda D; Marchman W; Alqaisi M; Larkin EW; Condie RM; Carobbi A; Thomas JM
Transplant Proc; 1990 Jun; 22(3):1083-5. PubMed ID: 1693452
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
